NCT02578186View on ClinicalTrials.gov

Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Occasional Sleeplessness
Interventions
DRUG

Diphenhydramine Hydrochloride

30 mL at bedtime

DRUG

Placebo

30 mL at bedtime

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT02578186 - Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness | Biotech Hunter | Biotech Hunter